Abstract-A number of neural network schemes have been applied to a large data base of pregnant women, aiming at generating a predictor for the estimation of the risk of occurrence of preeclampsia at an early stage. The database was composed of 6838 cases of pregnant women in UK, provided by the Harris Birthright Research Centre for Fetal Medicine in London. For each subject, 24 parameters were measured or recorded. Out of these, 15 parameters were considered as the most influencing at characterizing the risk of preeclampsia occurrence. A number of feedforward neural structures, both standard multilayer and multi-slab, were tried for the prediction. The best results obtained were with a multi-slab neural structure. In the training set there was a correct classification of the 83.6% cases of preeclampsia and in the test set 93.8%. The preeclampsia cases prediction for the totally unknown verification test was 100%.
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The time that preeclampsia may occur is during the late 2 nd or 3 rd trimester. It has also been observed that it is more common to women on their first pregnancy. The prevailing conditions that lead to preeclampsia are not well understood, hence its detection depends on signs or investigations. The likelihood of developing preeclampsia is increased by a number of factors in the maternal history, including Afro-Caribbean ethnicity, nulliparity, high body mass index (BMI), and previous or family history of preeclampsia [6] . However, screening by maternal history alone will detect only 30% of those who will develop the condition, with a false positive rate of 10%. Thus, the early diagnosis of preeclampsia is difficult, and the prognosis even more hard.
Attempts of preeclampsia prevention by using prophylac- [7] - [8] .
For these reasons, any tool that may improve the detection of preeclampsia, as for instance a reliable predictor or a method for the effective and early identification of the highrisk group, would be of great help to obstetricians and of course to pregnant women.
In recent years, neural networks and other computationally intelligent techniques have been used as medical diagnosis tools aiming at achieving effective medical decisions incorporated in appropriate medical support systems [9]- [11] . Neural networks in particular have proved to be quite effective and have also resulted in suitable patents [12] - [13] . II. DATA This study uses results of a prospective screening study for preeclampsia in singleton pregnancies from the greater London area and South-East England. All of the women were attending the clinical center for routine assessment of risk for chromosomal abnormalities. This is performed by measurement of fetal nuchal translucency thickness, maternal serum free human chorionic gonadotropin (thCG) and serum pregnancy-associated plasma protein A (PAPP-A) at 11 to 13+6 weeks of gestation. Gestational age was derived from the fetal crown-rump length (CRL).
Written informed consent was obtained from the women agreeing to participate in the study, which was approved by King's College Hospital Ethics Committee.
Patients were asked to complete a questionnaire on maternal age, ethnic origin (White, Afro-Caribbean, Indian or Pakistani, Chinese or Japanese, or mixed), cigarette smoking during pregnancy, alcohol intake during pregnancy, drug abuse during pregnancy, medical history, medication, parity (parous or nulliparous if no delivery beyond 23 weeks), obstetric history (including previous pregnancy with preeclampsia), and family history of preeclampsia (sister, mother, or both). The maternal weight and height were measured, and the BMI was calculated in kilograms per meter squared.
The Blood Pressure (BP) was taken by automated devices, and the arm with the highest final Mean arterial pressure (MAP) for the subsequent analysis of results was used [14] - [15] .
For the measurement of uterine artery pulsatility index (UPI) a sagittal section of the uterus was obtained with each uterine artery along the side of the cervix at the level of the internal cervical os. Pulsed wave Doppler was used with the sampling gate set at 2 mm to cover the whole vessel with the angle of insonation being less than 50 0 • When three similar consecutive waveforms were obtained, the UPI was measured and the mean PI of the left and right arteries was calculated.
The database was composed of 6838 cases of pregnant women. These were provided by the Harris Birthright Research Centre for Fetal Medicine (FMF) in London. For each woman, 24 parameters were logged. Some of these parameters were socio-epidemiologic, others were records from a clinical examination and a third group from laboratory measurements.
The number of cases that preeclampsia occurred were only 116, which is a very small sub-database (1.7%) to be used for training of a neural system aiming at achieving good generalization . The definitions of pre-eclamps ia used were those of the guidelines of the International Society for the Study of Hypertension in Pregnancy [16] .
From the available data some parameters were excluded, based on recommendations from medical experts, thus only 15 parameters, out of the total of 24, were ultimately considered as the most influencing at characterizing the risk of preeclampsia occurrence, and were used in the built-up of the neural predictor. These parameters are shown in Table 1.   TABLE I  PARAMETERS THAT WERE The parameters were encoded in appropriate numerical scales that could make the neural processing to be most effective.
A set of 36 cases was extracted and used to test the progress of training (test set). This data set included 16 cases (44%) of women that exhibited preeclampsia.
Also, a hold out verification data set having 9 cases of which 5 were with preeclampsia (56%), was also extracted to be used as totally unknown to the neural network, and thus to be used for checking the prediction capabilities of each attempted network.
Ill. N EURAL PREDICTOR
A number of feedforward neural structures, both standard multilayer -of varying number of layers and neurons per layer, as well as multi-slab of different structures, sizes, and activation functions, were systematically tried for the prediction. This was done in a planned manner so that the best architecture would be obtained.
Considering the results obtained by such a systematic search, it was possible to ultimately select and use a multislab neural structure having four slabs that were connected as depicted in Figure 1 .
All weights were initialized to 0.3, while the learning rate was the same for all connections, having value of 0.1. Similarly, the momentum rate was 0.2 for all links. These values were selected based on extensive experience the authors have, which was gained during many studies of medical and other classification and prediction using artificial neural networks .
The test set was applied at the end of each epoch to test the progress of training. If the results during testing at time t were better than those at time t -1, the weights were saved as a better set. At the end of the process, the best weight set was kept for the prediction. The training progress was monitored to observe whether there was improvement during the application of the training and test set data. For most of the network structures that were attempted, there was little generalization improvement after about 1200 epochs, as depicted in Figure 2 .
Different sets of inputs were used to find an effective neural structure that would predict preeclampsia to an acceptable level. The inputs that were ultimately selected are those shown in Table 1 .
Further to the artificial neural network structures that were developed as preeclampsia predictors, multiple linear regression and a form of multiple nonlinear regression were also explored as possible predictors.
The multiple nonlinear regression model used was of the form shown below. 
The results from the two regression methods were substantially inferior to those given by the neural structures, as will be explained in the following section.
In all cases the decision threshold has been set to 0.5. Table 3 shows the network prediction results for the 9 cases of the totally unknown verification test set. It is seen that the sensitivity (and the true positive fraction) is 100%, while the specificity is 50%, and the false positive fraction also 50%.
From a parameter contribution analysis it was observed that all 15 parameters contributed to the prediction. However, the mean arterial pressure and the uterine pulsatility index were the most influential, while the "Ethnicity" parameter was the least contributing .
IV. RESULTS
In Table 2 an overall picture of the prediction results of the best neural network is presented. The best results were obtained with a multi-slab neural structure of the type described in Figure 1 . In the training set, there was a correct classification of the 83.6% cases of preeclampsia and in the test set 93.8%. The preeclampsia cases predicted correctly for the totally unknown verification test set was 100%. In this set however, two subjects were predicted to exhibit preeclampsia, while they actually did not. As for the multiple linear regression and the multiple nonlinear regression, the prediction results were rather disappointing . A summary of the results is shown in Tables 4  and 5 . It is seen that their generalization capabilities are rather very poor, since both of the methods did not predict any preeclampsia cases for the totally unknown verification test set.
V. CONCLUSION AND FUTURE WORK
Attempts to predict preeclampsia using multivariate statistics have been reported in the past [17] , but the use of neural network methodologies is very rare [18] .
Furthermore, in other areas of fetal medicine prediction model methodologies have been equally necessary and clinically meaningful [19] - [20] .
Based on the results obtained, it may be concluded that the neural structure has been shown to be an effective and reliable predictor for this set of data. The neural network classifier certainly performed much better than the multiple linear regression and the multiple nonlinear regression. Indeed, it has identified all five preeclampsia cases in the totally unknown verification set. It also identified correctly two more cases as non-preeclamptic. However, it predicted preeclampsia for two unknown subjects, while these women did not manifest preeclampsia . This means that the doctors should probably look more carefully to such cases, which in any case were on the safe side.
The association between Afro-Caribbean race and obesity with increased risk of pre-eclampsia is well documented [17] ; [21] , a finding not supported by our study. This could be due to the small number of such cases in the training data set. Thus, the network needs to be tested further on a completely new and more expanded database of preeclampsia cases, involving a larger sample of Afro-Caribbean cases. Such a larger data set is not easily obtained, as it will be based on real people with real diseases, and not simulated data.
The choice of 11+0 to 13+6 weeks as the gestational age for screening was made because this has been established as the first hospital visit of pregnant women at which combined sonographic and biochemical testing for chromosomal and other major defects is carried out [22] .
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